Clinical Trial Update: Fexinidazole in Human African Trypanosomiasis Due to T.b. Gambiense at Any Stage [Phase 3]

View source ↗

Summary

Phase 3 trial results for fexinidazole in human African trypanosomiasis (Trypanosoma brucei gambiense) have been completed with results posted in June 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human African Trypanosomiasis

Drugs mentioned

• Fexinidazole (fexinidazole)

Snippet

Sponsor: Drugs for Neglected Diseases | Conditions: Trypanosomiasis, African, Sleeping Sickness | Phase 3 | Status: COMPLETED | Results posted: 2024-06-07